Co-Authors
This is a "connection" page, showing publications co-authored by Olatoyosi Odenike and John Cursio.
Connection Strength
0.279
-
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era. Blood Adv. 2024 07 09; 8(13):3468-3477.
Score: 0.221
-
Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms. Blood Neoplasia. 2025 May; 2(2):100089.
Score: 0.058